Literature DB >> 10449659

Early-onset fetal hydrops and muscle degeneration in siblings due to a novel variant of type IV glycogenosis.

P M Cox1, L A Brueton, K W Murphy, V C Worthington, P Bjelogrlic, E J Lazda, N J Sabire, C A Sewry.   

Abstract

We report on 3 consecutive sib fetuses, presenting at 13, 12, and 13 weeks of gestation, respectively, with fetal hydrops, limb contractures, and akinesia. Autopsy of the first fetus showed subcutaneous fluid collections and severe degeneration of skeletal muscle. Histologic studies demonstrated massive accumulation of diastase-resistant periodic acid-Schiff-positive material in the skeletal muscle cells and epidermal keratinocytes of all 3 fetuses. Enzyme studies of fibroblasts from the 3rd fetus showed deficient activity of glycogen brancher enzyme, indicating that this is a new, severe form of glycogenosis type IV with onset in the early second trimester. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449659     DOI: 10.1002/(sici)1096-8628(19990910)86:2<187::aid-ajmg20>3.0.co;2-7

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.

Authors:  B Giuffrè; R Parini; T Rizzuti; L Morandi; O P van Diggelen; C Bruno; M Giuffrè; G Corsello; F Mosca
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  A Novel Homozygous Missense Mutation of PIEZO1 Leading to Lymphatic Malformation-6 Identified in a Family With Three Adverse Pregnancy Outcomes due to Nonimmune Fetal Hydrops.

Authors:  Shuai Han; Xin Guo; Xiaogang Wang; Huijun Lin; Yiqi Yu; Jing Shu; Minyue Dong; Liwei Yang
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

Review 3.  Diagnosis of inherited disorders of liver metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.